Society ❯ Consumer Rights

Healthcare Access

Drug Affordability Economic Impact Pharmaceutical Pricing Patient Advocacy Prescription Drugs Affordability Issues Financial Burden Prescription Drug Costs Economic Inequality Insurance Coverage

Jury Finds Takeda Liable for Delaying Amitiza Generics, Awards $885 Million

Automatic trebling under antitrust law could push the total near $2.5 billion.

TrumpRx Expands With 600 Generic Drugs and New Discount Partners

Stories older than 24h

Singapore Insurers Unveil New IP Riders With Lower Premiums and Higher Patient Costs

Brazil Sets 2026 Medicine Price Caps With Three-Tier Increases Up to 3.81%

Analyses Find Limited Savings as TrumpRx Reaches 54 Drugs

DOJ and Ohio Sue OhioHealth Over Alleged Anticompetitive Insurance Contracts

Democratic Report Puts TrumpRx Under Fresh Scrutiny as Analyses Question Real-World Savings

White House Unveils 'Great Healthcare Plan' With Sparse Details, Big Budget Questions

Brazil’s Superior Court of Justice Rejects Semaglutide Patent Extension, Paving Way for 2026 Generics

Peru Fines 13 Drug Firms for Medicine Bid-Rigging as Health Ministry Pursues Damages

BBB Warns Denver Medical Supplier Over Alleged Unauthorized Medicare Billing

Mark Cuban’s Cost Plus Drugs Joins TrumpRx as Data Partner

Experts Question Impact of Trump’s Drug-Price Deals With Pfizer and AstraZeneca

White House Clinches Pfizer Pricing Deal Tied to Tariff Reprieve and $70 Billion U.S. Investment

HHS/CMS Widens Access to Catastrophic ACA Plans, Effective Nov. 1

AHPI–Bajaj Allianz Talks Advance After Cashless Advisory as Insurer Pledges Direct Payouts

Survey Finds 95% of Mexicans Use Generics as Government Frees 386 Drug Patents

Nine Category-B Prepagas Upload September Increases Ahead of July CPI Release

BGH Rules EU-Based Pharmacies May Offer Bonuses on Prescription Medicines

Frankfurt Court Bars Dutch Pharmacy From Offering €10 E-Prescription Vouchers